MELAX
Price
$15.34
Change
-$0.13 (-0.84%)
Updated
Nov 14 closing price
RNWFX
Price
$81.35
Change
-$0.39 (-0.48%)
Updated
Nov 14 closing price
Ad is loading...

MELAX vs RNWFX

Header iconMELAX vs RNWFX Comparison
Open Charts MELAX vs RNWFXBanner chart's image
Morgan Stanley Inst EMkts Ldrs A
Price$15.34
Change-$0.13 (-0.84%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$81.35
Change-$0.39 (-0.48%)
VolumeN/A
CapitalizationN/A
MELAX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MELAX vs. RNWFX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MELAX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 61.8B vs. MELAX (230M). RNWFX pays higher dividends than MELAX: RNWFX (1.51) vs MELAX (0.00). MELAX was incepted earlier than RNWFX: MELAX (10 years) vs RNWFX (23 years). MELAX is a more actively managed with annual turnover of: 54.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than MELAX: RNWFX (250) vs MELAX (1000). MELAX annual gain was more profitable for investors over the last year : 14.85 vs. RNWFX (13.53). MELAX return over 5 years is better than : 25.77 vs. RNWFX (18.88).
MELAXRNWFXMELAX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years23 years-
Gain YTD7.7308.66889%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets230M61.8B0%
Annual Yield % from dividends0.001.51-
Returns for 1 year14.8513.53110%
Returns for 3 years-27.91-13.10213%
Returns for 5 years25.7718.88136%
Returns for 10 yearsN/A43.17-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BFAM111.14-0.44
-0.39%
Bright Horizons Family Solutions
SENEA65.49-0.48
-0.73%
Seneca Foods Corp
UBS31.62-0.44
-1.37%
UBS Group AG
DTIL8.08-0.29
-3.46%
Precision BioSciences
SYRE32.97-2.84
-7.94%
Spyre Therapeutics